Indication-specific pricing makes therapy more affordable and accessible for all patients by aligning payment for a drug with the value it delivers to a particular patient population.
$25 Million Targeting Early-Stage Health Care Innovation
Our multi-year commitment to Lewis & Clark Ventures specifically targets new techologies and companies with the potential to provide early acces to the next big ideas in health care.
